Search

everythinglearnresearchcommunity

for

Search:↓

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Most patients were satisfied with diode laser hair removal and experienced no long-term side effects.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Both surgical and non-surgical hair loss treatments lack a standard treatment plan and sufficient patient satisfaction data.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Removing certain muscles during a browlift reduces glabellar wrinkles better long-term.

Frunevetmab injections in cats can cause severe itching and skin lesions.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Mothers with atopic dermatitis have higher risks of pregnancy complications and their children are more likely to develop certain health conditions.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Most children with MIS-C showed significant improvement by 6 months.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

High-quality validation studies are needed to improve alopecia areata patient-reported outcome measures.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.

Women with different PCOS types have similar fertility treatment results.